PARP Inhibitors: 2023 Updates

PARP inhibitors are playing an increasingly important role in treatment for many ovarian cancer patients, but have come under increasing scrutiny from the Food and Drug administration. Join Dr. Gini Fleming from ‪@UChicago‬ to get the latest on what's new with this class of drugs that have been a game-changer for so many.